GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,942,000 | +22.6% | 90,561 | +22.7% | 0.11% | +23.3% |
| Q1 2022 | $3,216,000 | +24.2% | 73,836 | +7.3% | 0.09% | -55.9% |
| Q3 2020 | $2,590,000 | -83.4% | 68,799 | -82.0% | 0.20% | -81.8% |
| Q2 2020 | $15,627,000 | -24.4% | 383,105 | -12.9% | 1.12% | -29.6% |
| Q4 2019 | $20,679,000 | +35.5% | 440,066 | +23.1% | 1.59% | -16.2% |
| Q3 2019 | $15,256,000 | +33.1% | 357,455 | +24.8% | 1.90% | +32.1% |
| Q2 2019 | $11,461,000 | +438.1% | 286,370 | +461.8% | 1.44% | +304.2% |
| Q1 2019 | $2,130,000 | -19.8% | 50,971 | -22.6% | 0.36% | +22.3% |
| Q2 2018 | $2,655,000 | +0.9% | 65,869 | -2.2% | 0.29% | -16.6% |
| Q1 2018 | $2,631,000 | -44.9% | 67,350 | -50.0% | 0.35% | +14.1% |
| Q4 2017 | $4,776,000 | +352.3% | 134,656 | +449.6% | 0.31% | +393.5% |
| Q2 2017 | $1,056,000 | +34.5% | 24,499 | +26.6% | 0.06% | -17.3% |
| Q1 2016 | $785,000 | -67.9% | 19,351 | -66.2% | 0.08% | -82.3% |
| Q4 2014 | $2,447,000 | – | 57,258 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |